These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 23592708)

  • 1. Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.
    Gheorghiade M; Fonarow GC; van Veldhuisen DJ; Cleland JG; Butler J; Epstein AE; Patel K; Aban IB; Aronow WS; Anker SD; Ahmed A
    Eur Heart J; 2013 May; 34(20):1489-97. PubMed ID: 23592708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure.
    Shah M; Avgil Tsadok M; Jackevicius CA; Essebag V; Behlouli H; Pilote L
    Am J Cardiol; 2014 Aug; 114(3):401-6. PubMed ID: 24950677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Digoxin Use Among Medicaid Enrollees With Atrial Fibrillation.
    Adedinsewo D; Xu J; Agasthi P; Oderinde A; Adekeye O; Sachdeva R; Rust G; Onwuanyi A
    Circ Arrhythm Electrophysiol; 2017 May; 10(5):e004573. PubMed ID: 28500174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased mortality among patients taking digoxin--analysis from the AFFIRM study.
    Whitbeck MG; Charnigo RJ; Khairy P; Ziada K; Bailey AL; Zegarra MM; Shah J; Morales G; Macaulay T; Sorrell VL; Campbell CL; Gurley J; Anaya P; Nasr H; Bai R; Di Biase L; Booth DC; Jondeau G; Natale A; Roy D; Smyth S; Moliterno DJ; Elayi CS
    Eur Heart J; 2013 May; 34(20):1481-8. PubMed ID: 23186806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin and Mortality in Patients With Atrial Fibrillation.
    Lopes RD; Rordorf R; De Ferrari GM; Leonardi S; Thomas L; Wojdyla DM; Ridefelt P; Lawrence JH; De Caterina R; Vinereanu D; Hanna M; Flaker G; Al-Khatib SM; Hohnloser SH; Alexander JH; Granger CB; Wallentin L;
    J Am Coll Cardiol; 2018 Mar; 71(10):1063-1074. PubMed ID: 29519345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.
    Freeman JV; Reynolds K; Fang M; Udaltsova N; Steimle A; Pomernacki NK; Borowsky LH; Harrison TN; Singer DE; Go AS
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):49-58. PubMed ID: 25414270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate-control versus rhythm-control strategies and outcomes in septuagenarians with atrial fibrillation.
    Shariff N; Desai RV; Patel K; Ahmed MI; Fonarow GC; Rich MW; Aban IB; Banach M; Love TE; White M; Aronow WS; Epstein AE; Ahmed A
    Am J Med; 2013 Oct; 126(10):887-93. PubMed ID: 24054956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation.
    Pastori D; Farcomeni A; Bucci T; Cangemi R; Ciacci P; Vicario T; Violi F; Pignatelli P
    Int J Cardiol; 2015 Feb; 180():1-5. PubMed ID: 25460369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digoxin and mortality in atrial fibrillation: a prospective cohort study.
    Hallberg P; Lindbäck J; Lindahl B; Stenestrand U; Melhus H;
    Eur J Clin Pharmacol; 2007 Oct; 63(10):959-71. PubMed ID: 17684738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study.
    Turakhia MP; Santangeli P; Winkelmayer WC; Xu X; Ullal AJ; Than CT; Schmitt S; Holmes TH; Frayne SM; Phibbs CS; Yang F; Hoang DD; Ho PM; Heidenreich PA
    J Am Coll Cardiol; 2014 Aug; 64(7):660-8. PubMed ID: 25125296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Digoxin Use and Adverse Outcomes Among Patients in the Chinese Atrial Fibrillation Registry.
    Gao Y; Chang S; Du X; Dong J; Xu X; Zhou Y; Lip GYH; Ma C
    Am J Cardiovasc Drugs; 2019 Dec; 19(6):579-587. PubMed ID: 31077081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 Trial.
    Eisen A; Ruff CT; Braunwald E; Hamershock RA; Lewis BS; Hassager C; Chao TF; Le Heuzey JY; Mercuri M; Rutman H; Antman EM; Giugliano RP
    J Am Heart Assoc; 2017 Jun; 6(7):. PubMed ID: 28666993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes in patients with atrial fibrillation treated with digoxin, according to the presence of heart failure: Insights from the MISOAC-AF trial.
    Botis M; Kartas A; Samaras A; Akrivos E; Vrana E; Liampas E; Papazoglou AS; Moysidis DV; Papanastasiou A; Baroutidou A; Karvounis H; Tzikas A; Parissis J; Drakos SG; Giannakoulas G
    Hellenic J Cardiol; 2022; 68():25-32. PubMed ID: 36037999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
    Washam JB; Stevens SR; Lokhnygina Y; Halperin JL; Breithardt G; Singer DE; Mahaffey KW; Hankey GJ; Berkowitz SD; Nessel CC; Fox KA; Califf RM; Piccini JP; Patel MR;
    Lancet; 2015 Jun; 385(9985):2363-70. PubMed ID: 25749644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digoxin-amiodarone Combination is Associated With Excess All-cause Mortality in Patients With Atrial Fibrillation.
    Chiang JY; Chen PC; Yang YH; Chang CH; Chu FY; Chen JJ; Wu CK; Hwang JJ; Chiang FT; Lin LY; Lin JL
    Sci Rep; 2020 Mar; 10(1):4101. PubMed ID: 32139765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses.
    Saksena S; Slee A; Waldo AL; Freemantle N; Reynolds M; Rosenberg Y; Rathod S; Grant S; Thomas E; Wyse DG
    J Am Coll Cardiol; 2011 Nov; 58(19):1975-85. PubMed ID: 22032709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A history of atrial fibrillation and outcomes in chronic advanced systolic heart failure: a propensity-matched study.
    Ahmed MI; White M; Ekundayo OJ; Love TE; Aban I; Liu B; Aronow WS; Ahmed A
    Eur Heart J; 2009 Aug; 30(16):2029-37. PubMed ID: 19531579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin use and risk of mortality in hypertensive patients with atrial fibrillation.
    Okin PM; Hille DA; Wachtell K; Kjeldsen SE; Boman K; Dahlöf B; Devereux RB
    J Hypertens; 2015 Jul; 33(7):1480-6. PubMed ID: 25799208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East.
    Al-Zakwani I; Panduranga P; Zubaid M; Sulaiman K; Rashed WA; Alsheikh-Ali AA; AlMahmeed W; Shehab A; Al Qudaimi A; Asaad N; Amin H
    J Cardiovasc Pharmacol Ther; 2016 May; 21(3):273-9. PubMed ID: 26341119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digoxin in patients with permanent atrial fibrillation: data from the RACE II study.
    Mulder BA; Van Veldhuisen DJ; Crijns HJ; Tijssen JG; Hillege HL; Alings M; Rienstra M; Van den Berg MP; Van Gelder IC;
    Heart Rhythm; 2014 Sep; 11(9):1543-50. PubMed ID: 24924587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.